Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : IPHA save search
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published: 2024-04-10 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -3.85%
H: 1.2%
C: 0.8%
iph45 pharma drug candidate antibody preclinical
Innate Pharma Announces Its Participation in Upcoming April 2024 Investor Conference
Published: 2024-04-09 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -0.38%
H: 0.95%
C: 0.83%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.57%
H: 1.81%
C: 1.81%
pharma conference
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published: 2024-04-05 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: -5.22%
pharma report universal
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-21 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -4.51%
H: 4.25%
C: 0.96%
pharma business year update financial results
Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published: 2024-03-19 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.84%
H: 4.56%
C: 0.83%
pharma conference
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 09:00) - biospace.com/
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -2.4%
H: 3.69%
C: 3.28%
pharma conference year financial results
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.78%
H: 1.93%
C: 0.97%
iph45 pharma drug antibody preclinical
Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
Published: 2024-03-06 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.78%
H: 1.93%
C: 0.97%
iph6501 first study
Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published: 2024-02-21 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -2.32%
H: 0.0%
C: 0.0%
pharma conference
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.18%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.06%
H: 2.34%
C: 2.29%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 0.37%
H: 0.74%
C: 0.28%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.34%
H: 0.23%
C: -1.13%
JNJ | News | $147.895 1.48% 5.8M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.22%
H: 0.07%
C: -0.43%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.96%
H: 1.75%
C: 1.75%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.18%
H: 0.48%
C: -1.91%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
ZLAB | News | $14.08 -0.99% -0.99% 470K
|
Health Technology
|
| O: -1.15%
H: 1.03%
C: -1.5%
VRTX | News | $394.265 0.2% 930K
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -0.32%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -3.1%
H: 1.2%
C: -0.8%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
BIIB | $193.75 1.7% 1M
|
Health Technology
|
| O: -3.72%
H: 0.58%
C: -3.82%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.26%
H: 0.73%
C: -0.36%
ARGX | $359.51 0.31% 280K
|
Health Technology
|
| O: -2.3%
H: 1.65%
C: 0.83%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -1.4%
expansion growth market
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published: 2024-01-12 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 0.36%
C: 0.36%
pharma
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published: 2024-01-04 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 1.12%
H: 0.93%
C: 0.77%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 6.47%
H: 3.65%
C: -2.36%
fda pharma program
Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
Published: 2024-01-04 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 1.12%
H: 0.93%
C: 0.77%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 6.47%
H: 3.65%
C: -2.36%
pharma
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.91%
H: 0.72%
C: 0.11%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 13.88%
H: 0.0%
C: -3.58%
pharma natural cell sanofi
Innate Pharma Announces Leadership Change - December 18, 2023
Published: 2023-12-18 (Crawled : 10:00) - biospace.com/
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 1.25%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.9%
H: 2.02%
C: -1.21%
pharma change
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Published: 2023-12-11 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 9.45%
H: 0.0%
C: -1.7%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.5%
H: 1.67%
C: 0.1%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -1.16%
H: 0.39%
C: -4.31%
sar4435 pharma iph6101 cell results sanofi
Innate Pharma to Host Virtual KOL Event on Lacutamab
Published: 2023-11-27 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 1.04%
H: 0.17%
C: 0.11%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.07%
H: 1.21%
C: 1.21%
pharma
Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
Published: 2023-11-14 (Crawled : 09:00) - biospace.com/
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 6.61%
H: 9.39%
C: 6.61%
pharma business update financial results
Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Published: 2023-11-07 (Crawled : 08:00) - biospace.com/
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -2.31%
H: 2.76%
C: 1.18%
pharma conference business update
Innate Pharma Announces Its Participation to Upcoming November 2023 Investor Conferences
Published: 2023-10-27 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -18.18%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -15.73%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -2.85%
H: 12.13%
C: 3.77%
pharma
Gainers vs Losers
| 63% | 37% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.